Sepio Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-298,545
| Closed | -$4.41M | – | 290 |
|
|
2024
Q1 | $4.41M | Sell |
298,545
-8,135
| -3% | -$120K | 0.38% | 48 |
|
|
2023
Q4 | $4.11M | Hold |
306,680
| – | – | 0.35% | 47 |
|
|
2023
Q3 | $3.78M | Buy |
306,680
+12,135
| +4% | +$150K | 0.33% | 68 |
|
|
2023
Q2 | $3.62M | Hold |
294,545
| – | – | 0.29% | 90 |
|
|
2023
Q1 | $3.62M | Hold |
294,545
| – | – | 0.33% | 82 |
|
|
2022
Q4 | $3.38M | Hold |
294,545
| – | – | 0.29% | 91 |
|
|
2022
Q3 | $1.11M | Sell |
294,545
-21,768
| -7% | -$81.7K | 0.11% | 181 |
|
|
2022
Q2 | $1.88M | Buy |
316,313
+19,767
| +7% | +$118K | 0.19% | 142 |
|
|
2022
Q1 | $1.88M | Buy |
296,546
+217,717
| +276% | +$1.38M | 0.16% | 155 |
|
|
2021
Q4 | $308K | Hold |
78,829
| – | – | 0.02% | 314 |
|
|
2021
Q3 | $381K | Sell |
78,829
-142,610
| -64% | -$689K | 0.03% | 296 |
|
|
2021
Q2 | $1.42M | Buy |
221,439
+2,532
| +1% | +$16.2K | 0.12% | 204 |
|
|
2021
Q1 | $1.38M | Buy |
218,907
+25,431
| +13% | +$160K | 0.13% | 190 |
|
|
2020
Q4 | $1.33M | Sell |
193,476
-1,309
| -0.7% | -$9.02K | 0.12% | 189 |
|
|
2020
Q3 | $779K | Sell |
194,785
-15,749
| -7% | -$63K | 0.08% | 196 |
|
|
2020
Q2 | $701K | Sell |
210,534
-143,110
| -40% | -$477K | 0.08% | 188 |
|
|
2020
Q1 | $760K | Sell |
353,644
-42,540
| -11% | -$91.4K | 0.1% | 138 |
|
|
2019
Q4 | $1.25M | Buy |
396,184
+166,708
| +73% | +$525K | 0.12% | 140 |
|
|
2019
Q3 | $1.03M | Buy |
+229,476
| New | +$1.03M | 0.11% | 151 |
|
|
2019
Q1 | – | Sell |
-523,240
| Closed | -$1.59M | – | 342 |
|
|
2018
Q4 | $1.59M | Buy |
+523,240
| New | +$1.59M | 0.12% | 116 |
|